Startups
2017
GLYCARDIAL DIAGNOSTICS SLImprove the early diagnosis of cardiac ischemic events to reduce the impact of the disease on patients' life
Apo J-Glyc as a novel biomarker for the diagnosis and prognosis of myocardial ischemia
Apo J-Glyc as a novel biomarker for the diagnosis and prognosis of myocardial ischemia
Address
Carrer de Baldiri Reixac 15, 08028 Barcelona, Spain
Finance Data
CERCA ownership
Barcelona, Spain
1992
Institut de Recerca Sant Pau
Other Catalan Public owners
Logo
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Product description
GlyCardial Diagnostics’ technology is based on the quantification of specific protein modifications as a novel and disruptive approach to detect cardiac ischemia
Company Closed or Exit Year